VivoSim Labs, Inc. Operating Lease, Weighted Average Discount Rate, Percent
VivoSim Labs, Inc. (VIVS) had Operating Lease, Weighted Average Discount Rate, Percent of 6.00% as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 6.00%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 6.00%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.00%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 6.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 6.00% 10-Q · filed 2026-08-12 |
| 2026-03-31 | 6.00% 10-K · filed 2026-07-14 |
| 2025-12-31 | 6.00% 10-Q · filed 2026-02-11 |
| 2025-09-30 | 6.00% 10-Q · filed 2025-11-06 |
| 2025-06-30 | 6.00% 10-Q · filed 2025-08-12 |
| 2025-03-31 | 6.00% 10-K · filed 2025-06-05 |
| 2024-12-31 | 6.00% 10-Q · filed 2025-02-19 |
| 2024-09-30 | 6.00% 10-Q · filed 2024-11-08 |
| 2024-06-30 | 6.00% 10-Q · filed 2024-08-05 |
| 2024-03-31 | 6.00% 10-K · filed 2024-05-31 |
| 2023-12-31 | 6.00% 10-Q · filed 2024-02-08 |
| 2023-09-30 | 6.00% 10-Q · filed 2023-11-09 |
| 2023-06-30 | 6.00% 10-Q · filed 2023-08-10 |
| 2023-03-31 | 6.00% 10-K · filed 2023-07-14 |
| 2022-12-31 | 6.00% 10-Q · filed 2023-02-09 |
| 2022-09-30 | 6.00% 10-Q · filed 2022-11-10 |
| 2022-06-30 | 6.00% 10-Q · filed 2022-08-11 |
| 2022-03-31 | 6.00% 10-K · filed 2022-06-10 |
| 2021-12-31 | 6.00% 10-Q · filed 2022-02-14 |
| 2019-09-30 | 8.00% 10-Q · filed 2019-11-07 |
| 2019-06-30 | 8.00% 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |